Clival Database

Power BI Dashboard
Free Trial/Demo
Client Login

About Us
Clinical Trial Data
Glossary Terms Drug Development Process Therapy Area/ Disease Sponsor/ Organisation Orphan Drug Designation Fast Track Approval Breakthrough Approval
Licensing Opportunities
CRO
News Center
Pricing
Contact Us

Home
Odd/Bta

Odd/Bta

Recent News

Everest Medicin...

March 11,2022 12:40 PM

SciSparc Launch...

March 11,2022 12:38 PM

Health Canada A...

March 11,2022 12:37 PM

Cerveau Technol...

March 11,2022 12:34 PM

Lupin Launches ...

March 11,2022 12:33 PM

I Mab Receives FDA Orphan Drug Designation For Cancer Drug
March 07,2022 10:19 AM

Inhibrx Receives FDA Orphan Drug Designation For INBRX 101 For The Treatment Of Alpha 1 Antitrypsin Deficiency
March 04,2022 10:10 AM

China NMPA Grants Breakthrough Designation To Innovent Biologics & AnHeart Therapeutics Taletrectinib In ROS1-positive NSCLC
March 03,2022 10:28 AM

Innovent Biologics And AnHeart Therapeutics Receive NMPA Breakthrough Designation For Taletrectinib In ROS1-Positive Non-Small Cell Lung Cancer
March 01,2022 10:22 AM

Boehringers Idiopathic Pulmonary Fibrosis Drug Gets Breakthrough Designation
February 26,2022 11:01 AM

Dizal Pharmaceutical Receives US FDA Fast Track Designation For DZD4205 (Golidocitinib) For The Treatment Of Refractory Or Relapsed Peripheral T-Cell
February 21,2022 09:59 AM

Revive Therapeutics Receives FDA Orphan Drug Designation For Bucillamine In The Prevention Of Ischemia Reperfusion Injury During Liver Transplantation
February 16,2022 10:31 AM

Rapid Medical Receives FDA Breakthrough Device Designation For Vasospasm Treatment
February 16,2022 10:04 AM

US FDA Grants Orphan Drug Designation To BCMA CAR-T Cell Therapy Co-Developed By IASO Bio And Innovent
February 15,2022 10:40 AM

US FDA Grants Fast Track Designation Bayers Asundexian Stroke Programme
February 11,2022 09:59 AM

Syros Receives FDA Orphan Drug Designation For Tamibarotene For The Treatment Of MDS
February 04,2022 10:30 AM

FDA Grants Breakthrough Therapy Designation For Dizal Pharmaceuticals DZD9008 In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Canc
January 28,2022 11:03 AM

Senhwas Silmitasertib Receives US FDA Orphan Drug Designation For The Treatment Of Biliary Tract Cancer
January 22,2022 10:37 AM

US FDA Grants Fast Track Status To Dynacures DYN101 To Treat Myotubular And Centronuclear Myopathies
January 10,2022 10:55 AM

Breakthrough Discoveries On Novel Features Of Omicron Variant And An Anti-Omicron Antibody JMB2002
January 04,2022 10:26 AM

NRx Pharma Seeks US FDA Breakthrough Therapy Status For Zyesami In Patients At Immediate Risk Of Death From Covid-19 Despite Treatment With Remdesivir
December 31,2021 10:35 AM

BioArctics Partner Eisai Receives US FDA Fast Track Designation For Lecanemab To Treat Alzheimers Disease
December 28,2021 10:29 AM

Lion TCR Receives FDA Fast Track Designation For Its HBV-specific TCR T Cell Therapy For Hepatocellular Carcinoma
December 24,2021 10:11 AM

Senhwas Silmitasertib Receives US FDA Orphan Drug Designation For The Treatment Of Medulloblastoma
December 20,2021 10:30 AM

Senhwas Silmitasertib Receives US FDA Orphan Drug Designation For The Treatment Of Medulloblastoma
December 20,2021 10:20 AM

Tocagen Inc Has Secured Orphan Drug Status For Its Investigational Gene Therapy Treatment For Glioblastoma
December 14,2021 10:53 AM

AZ Announces US Fast Track Designation For IL-5 Inhibitor Fasenra
December 11,2021 10:57 AM

NeurOp Receives FDA Orphan Drug Designation For NP10679 For Treatment Of Subarachnoid Hemorrhage
December 10,2021 10:12 AM

FDA Grants Orphan Drug Status To Cellects ApoGraft
December 09,2021 10:49 AM

TiGenixs Crohns Disease Drug Granted Swiss Orphan Drug Designation
December 08,2021 10:13 AM

Regenxbio Receives FDA Orphan Drug Designation For Potential Duchenne Treatment
December 07,2021 10:28 AM

Pfizer Is In Discussions With The US FDA About Altering Its Safety Warnings On Viagra
December 06,2021 11:21 AM

Onyx Pharmaceuticals Has Received A Fast Track Designation From The US FDA For Its Multiple Myeloma Drug Carfilzomib
December 06,2021 11:18 AM

AstraZenecas Selumetinib With Breakthrough Designation
December 03,2021 10:58 AM

European Medicines Agency Grants Orphan Drug Designation To Zydus Cadilas Saroglitazar Mg
December 03,2021 10:32 AM

Roche Snags Pair Of FDA Breakthrough Designations
December 02,2021 10:30 AM

US FDA Grants Orphan Drug Designation To IASO Bio’s CT120 To Treat ALL
November 30,2021 10:00 AM

Amgen Files Breakthrough Leukaemia Antibody In US
November 29,2021 10:12 AM

Novartis Receives FDA Breakthrough Therapy Designation For Rare Disease Med
November 26,2021 10:37 AM

Relief Announces US FDA Denies Breakthrough Designation To NRx Pharma’s Aviptadil
November 26,2021 10:05 AM

FDA Moves To Tackle Orphan Designation Backlog
November 25,2021 10:39 AM

Vertex Gains FDA Fast Track Designation For Diabetes Stem Cell Therapy
November 24,2021 10:14 AM

Lilly Wins Breakthrough Designation For Breast Cancer Drug
November 24,2021 10:12 AM

FDA Grants Orphan Drug Status To UniQures Huntingtons Disease Treatment
November 23,2021 10:41 AM

US FDA Grants Orphan Drug Status To Gracells FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy GC012F To Treat Multiple Myeloma
November 22,2021 09:52 AM

EC Grants MSDs Prevymis Orphan Product Designation
November 19,2021 10:37 AM

Gilead Drops Remdesivirs Orphan Drug Designation
November 18,2021 10:31 AM

UNION Therapeutics Receives FDA Fast Track Designation For Oral Orismilast For The Treatment Of Moderate To Severe Atopic Dermatitis
November 17,2021 10:26 AM

Junshi Biosciences And Coherus Announce Toripalimab Granted Orphan Drug Designation In The United States For Esophageal Cancer
November 16,2021 10:08 AM

Drug Delivery NanoSmart Receives Second FDA Orphan Drug Designation For Treatment Of Pediatric Cancer
November 15,2021 11:20 AM

TransThera Receives Fast Track Designation From FDA For Its Core Product TT-00420 To Treat Cholangiocarcinoma
November 12,2021 10:22 AM

FDA Grants Orphan Drug Designation To Elamipretide For LHON
November 11,2021 10:08 AM

FDA Grants Orphan Drug Designation To Phenylketonuria Treatment
November 10,2021 10:18 AM

FDA Grants Profounda Orphan Drug Designation Approval For Treatment Of Treatment Of Invasive Candidiasis With Miltefosine
November 09,2021 09:57 AM

Tinostamustine Granted Orphan Drug Designation By European Commission
November 08,2021 10:58 AM

Breakthrough For Indian Pharmaceutical Industry In China As First Anti-cancer Drug From India Enters Chinese Markets
November 03,2021 10:14 AM

US FDA Grants Breakthrough Therapy Designation To F2Gs Olorofim
October 22,2021 10:04 AM

Roches Anti-amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation In Alzheimers Disease
October 18,2021 09:48 AM

Roches Anti Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation In Alzheimers Disease
October 14,2021 09:54 AM

European Medicines Agency Grants Orphan Drug Designation To Zydus Cadilas Saroglitazar Mg
October 12,2021 09:46 AM

Roches Anti Amyloid Beta Antibody Gantenerumab Gets US FDA Breakthrough Therapy Designation To Treat Alzheimers Disease
October 11,2021 09:25 AM

European Medicines Agency Grants Orphan Drug Designation To Zydus Cadilas Saroglitazar Mg
October 06,2021 09:48 AM

Chugai Pharmas Hemlibra Gets Japanese Orphan Drug Designation To Treat Acquired Hemophilia A
October 05,2021 09:39 AM

USFDA Grants Orphan Drug Designation To Zydus Cadilas Saroglitazar Mg
October 04,2021 09:55 AM

Rhizen Receives USFDA Orphan Drug Designation For Cancer Drug
September 28,2021 09:43 AM

Piramal Pharma Solutions To Tie Up With Epirium Bio For Orphan Drugs
September 24,2021 09:59 AM

Rhizen Receives USFDA Orphan Drug Designation For Cancer Drug
September 21,2021 09:35 AM

FDA Grants Orphan Drug Designation In The US For CAM2029 For The Treatment Of Polycystic Liver Disease
September 18,2021 09:42 AM

Versantis Receives US FDA Orphan Drug Designation For VS-01
September 11,2021 10:14 AM

Savicell Diagnostics Achieves Breakthrough In Early Detection Of CancerImmunoBiopsy™ Platform Achieves High Accuracy; 97% Sensitivity And 97% Specif
September 11,2021 10:03 AM

Versantis Receives US FDA Orphan Drug Designation For VS-01
September 08,2021 09:22 AM

Prilenia Receives Positive EMA Opinion On Orphan Drug Designation For Pridopidine In ALS
July 19,2021 02:49 PM

Soleno Therapeutics Receives Orphan Drug Designation From FDA For Diazoxide Choline For The Treatment Of Glycogen Storage Disease Type 1a
July 19,2021 02:42 PM

Categories

Approval
Licensing Deal
New Indication Trial
Discontinued/Warning
Clinical Trial Update
Acquisition/Merger
Odd/Bta
Patent

Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.

Terms & Conditions | Privacy Policy | Disclaimer | Sitemap

Quick Links

About Us
Contact us
Pricing
Licensing Opportunities
CRO
Refund Policy

C-89 1st Floor, Sector-65 Noida-U.P. 201301 (India)

INDIA : +91-120-6631301-335

US : +1-201-688-7280

sales@lifescienceintellipedia.com

info@lifescienceintellipedia.com

© Copyright 2021 All right reserved, Lifescience Intellipedia Pvt. Ltd.